These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35116813)

  • 1. Clinicopathological and prognostic significance of NCALD protein expression in lung adenocarcinoma.
    Chen Y; Feng X; Shen H; Zhang L; Li X; Gao L; Zhang X; Wang B
    Transl Cancer Res; 2019 Jun; 8(3):752-760. PubMed ID: 35116813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
    Zhong K; Yang F; Han Q; Chen J; Wang J
    Oncol Lett; 2018 Sep; 16(3):2873-2880. PubMed ID: 30127874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
    Liu T; Xu S; Liu X
    Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma.
    Yuan K; Gao ZJ; Yuan WD; Yuan JQ; Wang Y
    Int J Clin Exp Pathol; 2018; 11(2):720-726. PubMed ID: 31938158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
    Kaishang Z; Xue P; Shaozhong Z; Yingying F; Yan Z; Chanjun S; Zhenzhen L; Xiangnan L
    Life Sci; 2018 Dec; 215():159-169. PubMed ID: 30391462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
    Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J
    Front Oncol; 2020; 10():598437. PubMed ID: 33569346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis.
    He C; Huang D; Yang F; Huang D; Cao Y; Peng J; Luo X
    Cancer Manag Res; 2022; 14():503-514. PubMed ID: 35173484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer.
    Feng LY; Li L
    J Ovarian Res; 2020 Mar; 13(1):35. PubMed ID: 32228639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of SPARC expression in non-small cell lung cancer: A meta-analysis and bioinformatics analysis.
    Ma GY; Shi S; Zhang YR; Guo ZB; Bai WW; Zhang ZG
    Oncol Lett; 2022 Nov; 24(5):412. PubMed ID: 36245823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study.
    Lu D; Ma Z; Huang D; Zhang J; Li J; Zhi P; Zhang L; Feng Y; Ge X; Zhai J; Jiang M; Zhou X; Simone CB; Neal JW; Patel SR; Yan X; Hu Y; Wang J
    Transl Lung Cancer Res; 2022 Jun; 11(6):1119-1131. PubMed ID: 35832445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
    Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
    J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential
    Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key genes in lung adenocarcinoma based on a competing endogenous RNA network.
    Song Z; Zhang Y; Chen Z; Zhang B
    Oncol Lett; 2021 Jan; 21(1):60. PubMed ID: 33281971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
    Chen S; Duan H; Xie Y; Li X; Zhao Y
    Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X; Chen L; Zhang T
    Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma.
    Li Z; Li F; Pan C; He Z; Pan X; Zhu Q; Wu W; Chen L
    Lung Cancer; 2021 Apr; 154():69-75. PubMed ID: 33626488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.